Brief: HeartBeam Reports Fourth Quarter And Full Year 2022 Financial Results
16/03/2023 22:39
March 16 (Reuters) - HeartBeam Inc BEAT.O :
* HEARTBEAM REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS
* HEARTBEAM INC - INITIAL FDA SUBMISSION OF HEARTBEAM
AIMIGO™,
TELEHEALTH SOLUTION, PROJECTED FOR Q2 2023
Source text for Eikon: ID:nBw9hDjSta
Further company coverage: BEAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heartbeam
See all newsBrief: Heartbeam Announces Strategic Shift To Accelerate Global Adoption Of Its Ambulatory ECG Signal Platform And Leadership Transition
Brief: Heartbeam Reports First Quarter 2026 Results
HeartBeam Q1 net loss narrows as commercialization advances
Brief: Heartbeam Initiates Pilot Study Of First On-Demand 12-Lead ECG Patch To Detect Ischemia Outside The Clinic
Brief: Heartbeam Expands Commercial Presence Across Four Key U.S. Markets With Addition Of Premier Concierge Practice